Efficacy of the Bonebridge BCI602 for Adult Patients with Single-sided Deafness : A Prospective Multicenter Study
© 2023 American Academy of Otolaryngology-Head and Neck Surgery Foundation..
OBJECTIVE: To investigate the safety and efficacy of a novel active transcutaneous bone conduction implant (BCI) device for patients with single-sided deafness (SSD).
STUDY DESIGN: Prospective cohort study.
SETTING: Tertiary referral hospitals.
METHODS: This prospective multicenter study was conducted at 15 institutions nationwide. Thirty adult (aged ≥19 years) SSD patients were recruited. They underwent implantation of an active transcutaneous BCI device (Bonebridge BCI602). Objective outcomes included aided pure-tone thresholds, aided speech discrimination scores (SDSs), and the Hearing in Noise Test (HINT) and sound localization test results. The Bern Benefit in Single-Sided Deafness (BBSS) questionnaire, the Abbreviated Profile of Hearing Aid Benefit (APHAB) questionnaire, and the Tinnitus Handicap Inventory (THI) were used to measure subjective benefits.
RESULTS: The mean aided pure-tone threshold was 34.2 (11.3), mean (SD), dB HL at 500 to 4000 Hz. The mean total BBSS score was 27.5 (13.8). All APHAB questionnaire domain scores showed significant improvements: ease of communication, 33.6 (23.2) versus 22.6 (21.3), P = .025; reverberation, 44.8 (16.6) versus 32.8 (15.9), P = .002; background noise, 55.5 (23.6) versus 35.2 (18.1), P < .001; and aversiveness, 36.7 (22.8) versus 25.8 (21.4), P = .028. Moreover, the THI scores were significantly reduced [47.4 (30.1) versus 31.1 (27.0), P = .003]. Congenital SSD was a significant factor of subjective benefit (-11.643; 95% confidence interval: -21.946 to -1.340).
CONCLUSION: The BCI602 active transcutaneous BCI device can provide functional hearing gain without any adverse effects and is a feasible option for acquired SSD patients with long-term deafness.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:170 |
|---|---|
| Enthalten in: |
Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery - 170(2024), 2 vom: 09. Jan., Seite 490-504 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Kim, Hantai [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Active transcutaneous bone conduction implant |
|---|
| Anmerkungen: |
Date Completed 19.01.2024 Date Revised 19.01.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1002/ohn.520 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM363048855 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM363048855 | ||
| 003 | DE-627 | ||
| 005 | 20240119231907.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1002/ohn.520 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1264.xml |
| 035 | |a (DE-627)NLM363048855 | ||
| 035 | |a (NLM)37811702 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Kim, Hantai |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Efficacy of the Bonebridge BCI602 for Adult Patients with Single-sided Deafness |b A Prospective Multicenter Study |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 19.01.2024 | ||
| 500 | |a Date Revised 19.01.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2023 American Academy of Otolaryngology-Head and Neck Surgery Foundation. | ||
| 520 | |a OBJECTIVE: To investigate the safety and efficacy of a novel active transcutaneous bone conduction implant (BCI) device for patients with single-sided deafness (SSD) | ||
| 520 | |a STUDY DESIGN: Prospective cohort study | ||
| 520 | |a SETTING: Tertiary referral hospitals | ||
| 520 | |a METHODS: This prospective multicenter study was conducted at 15 institutions nationwide. Thirty adult (aged ≥19 years) SSD patients were recruited. They underwent implantation of an active transcutaneous BCI device (Bonebridge BCI602). Objective outcomes included aided pure-tone thresholds, aided speech discrimination scores (SDSs), and the Hearing in Noise Test (HINT) and sound localization test results. The Bern Benefit in Single-Sided Deafness (BBSS) questionnaire, the Abbreviated Profile of Hearing Aid Benefit (APHAB) questionnaire, and the Tinnitus Handicap Inventory (THI) were used to measure subjective benefits | ||
| 520 | |a RESULTS: The mean aided pure-tone threshold was 34.2 (11.3), mean (SD), dB HL at 500 to 4000 Hz. The mean total BBSS score was 27.5 (13.8). All APHAB questionnaire domain scores showed significant improvements: ease of communication, 33.6 (23.2) versus 22.6 (21.3), P = .025; reverberation, 44.8 (16.6) versus 32.8 (15.9), P = .002; background noise, 55.5 (23.6) versus 35.2 (18.1), P < .001; and aversiveness, 36.7 (22.8) versus 25.8 (21.4), P = .028. Moreover, the THI scores were significantly reduced [47.4 (30.1) versus 31.1 (27.0), P = .003]. Congenital SSD was a significant factor of subjective benefit (-11.643; 95% confidence interval: -21.946 to -1.340) | ||
| 520 | |a CONCLUSION: The BCI602 active transcutaneous BCI device can provide functional hearing gain without any adverse effects and is a feasible option for acquired SSD patients with long-term deafness | ||
| 650 | 4 | |a Multicenter Study | |
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a active transcutaneous bone conduction implant | |
| 650 | 4 | |a bone conduction implant | |
| 650 | 4 | |a bonebridge | |
| 650 | 4 | |a single-sided deafness | |
| 700 | 1 | |a Park, Moo Kyun |e verfasserin |4 aut | |
| 700 | 1 | |a Park, Shi Nae |e verfasserin |4 aut | |
| 700 | 1 | |a Cho, Hyong-Ho |e verfasserin |4 aut | |
| 700 | 1 | |a Choi, Jae Young |e verfasserin |4 aut | |
| 700 | 1 | |a Lee, Chi Kyou |e verfasserin |4 aut | |
| 700 | 1 | |a Lee, Il-Woo |e verfasserin |4 aut | |
| 700 | 1 | |a Moon, Il Joon |e verfasserin |4 aut | |
| 700 | 1 | |a Jung, Jae Yun |e verfasserin |4 aut | |
| 700 | 1 | |a Jung, Jinsei |e verfasserin |4 aut | |
| 700 | 1 | |a Lee, Kyu-Yup |e verfasserin |4 aut | |
| 700 | 1 | |a Oh, Jeong-Hoon |e verfasserin |4 aut | |
| 700 | 1 | |a Park, Hong Ju |e verfasserin |4 aut | |
| 700 | 1 | |a Seo, Jae-Hyun |e verfasserin |4 aut | |
| 700 | 1 | |a Song, Jae-Jin |e verfasserin |4 aut | |
| 700 | 1 | |a Ha, Jungho |e verfasserin |4 aut | |
| 700 | 1 | |a Jang, Jeong Hun |e verfasserin |4 aut | |
| 700 | 1 | |a Choung, Yun-Hoon |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery |d 1982 |g 170(2024), 2 vom: 09. Jan., Seite 490-504 |w (DE-627)NLM012595721 |x 1097-6817 |7 nnns |
| 773 | 1 | 8 | |g volume:170 |g year:2024 |g number:2 |g day:09 |g month:01 |g pages:490-504 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1002/ohn.520 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 170 |j 2024 |e 2 |b 09 |c 01 |h 490-504 | ||